Philip Miller
Amgen
2 Papers
66 Citations
Philip Miller is an academic researcher from Amgen. The author has contributed to research in topics: Calcium-sensing receptor & Calcimimetic. The author has an hindex of 2, co-authored 2 publications.
Chat about Author
Papers
Patent
Calcium receptor modulating agents
Michael G. Kelly,Shimin Xu,Ning Xi,Philip Miller,John Kincaid,Chiara Ghiron,Thomas S. Coulter +6 more
- 23 May 2003
TL;DR: In this paper, the authors describe methods of treating diseases or disorders related to the function of the calcium sensing receptor using the compounds represented in Formula I. The present invention relates generally to novel calcimimetic compounds and pharmaceutical compositions comprising them.
40
Patent
Calcium receptor modulating arylalkylamines
Michael G. Kelly,Shimin Xu,Ning Xi,Philip Miller,John Kincaid,Chiara Ghiron,Thomas S. Coulter +6 more
- 23 May 2003
TL;DR: The compounds of the invention are represented by the following general structure (I) or a pharmaceutically acceptable salt thereof, and compositions containing them, wherein the variables are defined herein, and their use to reduce or inhibit PTH secretion, including methods for reducing or inhibiting PTH, and methods for treatment or prophylaxis of diseases associated with bone disorders, such as osteoporosis, or associated with excessive secretion of PTH such as hyperparathyroidism as mentioned in this paper.
26